Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure;Ensayo clínico aleatorizado de un programa de atención farmacéutica al alta frente a seguimiento habitual en pacientes con insuficiencia cardiaca

Farmacia Hospitalaria

Volumn 30, Issue 6, 2006, Pages 328-342

  Lopez Cabezas C ^a,c,d   Falces Salvador, C ^a,d   Cubi Quadrada D ^a,d   Arnau Bartes A ^a,d   Ylla Bore M ^a,d   Muro Perea, N ^b,e   Homs Peipoch, E ^a,d  

^a General Hospital of Vic   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Hospital General de Vic ^*  (Spain)

^d HOSPITAL GENERAL DE VIC   (Spain)

^e Hospital Municipal de Badalona   (Spain)

Author keywords

Heart failure; Hospital discharge; Pharmaceutical care; Randomized clinical trial; Re admission; Treatment compliance

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LOOP DIURETIC AGENT; NITRITE; SPIRONOLACTONE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; DIET THERAPY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACEUTICAL CARE; PHARMACIST; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TELEPHONE;

EID: 33846818843     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(06)74004-1     Document Type: Article

References (30)

1. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
2. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-55.
3. Panadero Cajaravilla FJ. Insuficiencia cardiaca. Panorama Actual del Medicamento 1997; 21: 88-94.
4. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348: 2007-19.
5. II Reunión Anual de la Sección de Insuficiencia Cardiaca de la Sociedad Española de Cardiología. La Coruña, junio 2005.
6. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 1997; 102: 43-9.
7. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433-7.
8. Adherence to long-term therapies. Evidence for action. WHO 2003.
9. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348: 383-6.
10. Walma EP, Hols AW, van Doren C, Prins A, van der Does E. Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial. BMJ 1997; 315: 464-8.
11. Chui MA, Deer M, Bennett SJ, Tu W, Oury S, Brater DC, Murray M. Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy 2003; 23: 326-32.
12. Rich MW, Beckham V, Wittenberg C, Leven CL, Freeland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-5.
13. Gattis W, Hasselblad V, Whellan D, O'Connor C. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team (PHARM Sudy). Arch Intern Med 1999; 159: 1939-45.
14. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: A randomised controlled study. Lancet 1999; 354: 1077-83.
15. Blue L, Lang E, McMurray J, Davie AP, McDonagh TA, Murdoch DR, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 2001; 323: 715-8.
16. Riegel B, Carlson B, Kopp Z, LePetri B, Glaser D, Unger A. Effect of a standardized nurse-case management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 2002; 162: 705-12.
17. Atienza F, Anguita M, Martínez-Alzamora N, Osca J, Ojeda S, Almenar L, et al. PRICE Study Group. Multicentre randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail 2004; 6: 643-52.
18. DeBusk RF, Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ, et al. Care management for low-risk patients with heart failure. Ann Intern Med 2004; 141: 606-13.
19. Galbreath AD, Krasuski RA, Smith B, Stajduhar KC, Kwan MD, Ellis R, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004; 110: 3518-26.
20. Koelling TM, Johnson ML, Cody RJ, Aaronson KD. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation 2005; 111: 179-85.
21. Morcillo C, Valderas JM, Aguado O, Delás J, Dort D, Pujadas R, et al. Evaluación de una intervención domiciliaria en pacientes con insuficiencia cardiaca. Resultados de un estudio aleatorizado. Rev Esp Cardiol 2005; 58: 618-25.
22. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure. A meta-analysis. JAMA 2004; 291: 1358-67.
23. Gil V, Pineda M, Martínez JL, Belda J, Santos ML, Merino J. Validez de 6 métodos indirectos para valorar el cumplimiento terapéutico en hipertensión arterial. Med Clin (Bare) 1994: 102: 532-6.
24. Badia X, Roset M, Montserrat S, Herdman M, Segura A. La versión española de EuroQol: descripción y aplicaciones. Med Clin (Barc) 1999; 112 (Supl. 1): 79-85.
25. Badia X, Schiaffino A, Alonso J, Herdman M. Using the EuroQol 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res 1998; 7: 311-22.
26. Guyatt GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993; 22 (Supl. A): 185-91.
27. McDonald HP, Garg AX, Haynes B. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002; 288: 2868-79.
28. Wagner EH. Deconstructing heart failure disease management. Ann Intern Med 2004; 141: 644-6.
29. Anguita M, Ojeda S, Atienza F, Ridocci F, Almenar L, Vallés F, et al. Análisis de coste-beneficio de los programas de prevención de reingresos en pacientes hospitalizados por insuficiencia cardiaca. Rev Esp Cardiol 2005; 58 (Supl. 2): 32-6.
30. Sokol M, McGuigan K, Verbrugge R, Epstein R. Impact of medication adherence on hospitalization risk and health cost. Med Care 2005; 43: 21-30.